torsemide has been researched along with Cardiomyopathy, Dilated in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arumugam, S; Harima, M; Karuppagounder, V; Nakamura, M; Sone, H; Sreedhar, R; Suzuki, H; Watanabe, K | 1 |
Ding, GL; Guo, SL; Han, LN; Lin, XM; Shi, XM; Yang, LM; Zang, CB | 1 |
Antony, S; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Nakamura, M; Sone, H; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
4 other study(ies) available for torsemide and Cardiomyopathy, Dilated
Article | Year |
---|---|
Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy.
Topics: Animals; Autoimmunity; Biomarkers; Cardiac Myosins; Cardiomyopathy, Dilated; Disease Models, Animal; Endoplasmic Reticulum Stress; Fibrosis; Heart Ventricles; Male; Mineralocorticoid Receptor Antagonists; Myocarditis; Rats, Inbred Lew; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone; Sulfonamides; Torsemide; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.
Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disease Progression; Diuretics; Echocardiography, Doppler, Color; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Incidence; Male; Middle Aged; Prognosis; Sulfonamides; Torsemide; Treatment Outcome | 2014 |
Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
Topics: Animals; Cadherins; Cardiac Myosins; Cardiomyopathy, Dilated; Connexin 43; Connexins; Disease Models, Animal; Furosemide; Gene Expression Regulation; Heart Failure; Humans; Rats; Sulfonamides; Swine; Torsemide | 2017 |
Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
Topics: Animals; Atrial Natriuretic Factor; Body Weight; Cardiomyopathy, Dilated; Collagen Type III; Disease Progression; Diuretics; Heart Failure; Male; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; RNA, Messenger; Sulfonamides; Torsemide; Transforming Growth Factor beta1; Ventricular Function, Left | 2008 |